We are live on
!
Find out more
Anika Therapeutics
ANIK
ANIK
162 hedge funds and large institutions have $537M invested in Anika Therapeutics in 2016 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 60 increasing their positions, 55 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
71% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 14
57% more call options, than puts
Call options by funds: $2.38M | Put options by funds: $1.51M
13% more capital invested
Capital invested by funds: $474M → $537M (+$63.1M)
7% more funds holding
Funds holding: 152 → 162 (+10)
9% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 55
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
162
Holders Change
+10
Holders Change %
+6.58%
% of All Funds
4.32%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
24
Increased
60
Reduced
55
Closed
14
Calls
$2.38M
Puts
$1.51M
Net Calls
+$864K
Net Calls Change
-$382K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$7.6M |
| 2 |
FAM
Fred Alger Management
New York
|
+$5.63M |
| 3 |
CM
Capital Management
Glen Allen,
Virginia
|
+$4.76M |
| 4 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
+$4.53M |
| 5 |
NAP
New Amsterdam Partners
New York
|
+$4.39M |
